(Q28182155)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14602238

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

29 March 2024

2

0 references

author name string

Mirjana Urosevic

full work available at URL

1

0 references

language of work or name

English

0 references

publication date

November 2003

0 references

https://api.elsevier.com/content/article/PII:S0198885903005391?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

https://api.elsevier.com/content/article/PII:S0198885903005391?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

29 March 2024

0 references

64

0 references

issue

11

0 references

page(s)

1073-80

0 references

cites work

Cancer immunoediting: from immunosurveillance to tumor escape

1

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G: a tolerance molecule from the major histocompatibility complex

29 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G: a shield against inflammatory aggression

29 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

29 March 2024

HLA-G remains a mystery

4

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G and IL-10 expression in human cancer--different stories with the same message

29 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G and its KIR ligands in cancer--another enigma yet to be solved?

29 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Human leukocyte antigen-G: immunotolerant major histocompatibility complex molecule in transplantation

29 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Skin cancers after organ transplantation

29 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status

29 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Sunburn and p53 in the onset of skin cancer

29 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Ultraviolet radiation and tumor immunity

29 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Immune escape mechanisms in malignant melanoma

29 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations

29 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions

29 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

29 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

In search of the 'missing self': MHC molecules and NK cell recognition

29 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Natural killer cells as potential tools in melanoma metastatic spread control

29 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

29 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression

29 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Expression of HLA G in human tumors is not a frequent event.

29 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Analysis of HLA-G expression in tumor cell lines

29 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

29 March 2024

Interferons in melanoma.

25

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801

29 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

29 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

29 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Expression of stress-induced MHC class I related chain molecules on human melanoma

29 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

29 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

29 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

29 March 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Production of Cytokines by Human Melanoma Cells and Melanocytes

29 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Expression of interleukin 10 in human melanoma.

29 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

29 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Cytokines and immune response in the tumor microenvironment

29 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.

29 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

29 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months

29 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Pathogenesis of cutaneous lymphomas

29 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

The immunopathogenesis of cutaneous T-cell lymphoma.

29 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Cytokines and cutaneous T-cell lymphomas

29 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Cytokine expression in primary cutaneous germinal center cell lymphomas

29 March 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

29 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor

29 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Serological detection of cutaneous T-cell lymphoma-associated antigens

29 March 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Major histocompatibility complex abnormalities in non-Hodgkin lymphomas

29 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course

29 March 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia

29 March 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G class I gene expression in normal and malignant hematopoietic cells

29 March 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G transcription studies during the different stages of normal and malignant hematopoiesis

29 March 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

29 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling

29 March 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

29 March 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

How do NK cells sense the expression of HLA-G class Ib molecules?

29 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

29 March 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

29 March 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas

29 March 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior

29 March 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

The clinicopathologic spectrum of cytotoxic lymphomas of the skin

29 March 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas

29 March 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Immunotherapy for nonmelanoma skin cancer: does it have a future?

29 March 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

The scientific basis of skin cancer

29 March 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Immune-associated cells in basal cell carcinomas of skin

29 March 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?

29 March 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells

29 March 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients.

29 March 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation

29 March 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Implication of HLA-G molecule in heart-graft acceptance.

29 March 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection

29 March 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection.

29 March 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule

29 March 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.HUMIMM.2003.08.351

29 March 2024

Identifiers